News
Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ...
Experts disagree on best strategies to prevent a rare, devastating complication: when patients with diffuse large B-cell ...
The approval of the new nasal spray comes ahead of this year's influenza season in hopes to prevent the unusually high ...
The Department of Trade and Industry (DTI), through the Philippine Economic Zone Authority (PEZA), has teamed up with ...
Inquirer Business on MSN7h
DTI, AstraZeneca to develop Pharma Innovation Hub
MANILA, Philippines - The government is partnering with the local subsidiary of multinational pharmaceutical company ...
The Department of Trade and Industry, through the Philippine Economic Zone Authority (PEZA), sealed a partnership with ...
FluMist Home is an influenza vaccine that’s administered via nasal spray, which means no needles and no waiting in line at ...
Elizabeth Bodin is very excited about the FDA-approved FluMist, a nasal spray that can be ordered online and delivered to ...
The Philippine Economic Zone Authority (Peza) has sealed a deal with AstraZeneca Pharmaceuticals (Phils.) to establish the country’s first pharma innovation hub, a flagship project aimed at boosting ...
BusinessWorld on MSN12h
AstraZeneca to build Philippines’ first pharma innovation hub
THE Department of Trade and Industry (DTI) said it tapped AstraZeneca Pharmaceuticals to help build the Philippines’ first pharma innovation hub. The hub stems from a memorandum of understanding (MoU) ...
AstraZeneca (LSE:AZN) recently launched "FluMist Home," an at-home flu vaccine delivery service, marking an important ...
AstraZeneca PLC closed 12.32% short of its 52-week high of £133.88, which the company achieved on September 3rd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback